Market Drivers:

IVF is going to be the new normal in human reproduction systems as many people are affected with infertility issues. According to the World Health Organization, 1 in 6 people are diagnosed with some infertility issues. Therefore, the prominence of IVF is significantly increasing these days. Sedentary lifestyles and eating unhealthy foods, especially among teenagers, are apparently leading to infertility, which is also attributed to leveraging the growth rate of the market.

In this modern period, women are mostly working and are likely to delay childbearing which is certainly one of the major factors for the rising age-related fertility issues that is rising the prevalence for the invitro fertilization treatment procedures. Many people around the world choose to have a child once they are financially stable, which takes a certain amount of time when complications arise, especially in women, due to stress. A stressful life poses a severe impact on fertility, which is certainly a factor for people are unable to conceive for the past few years. Advanced technology in healthcare infrastructure is making everything possible, like freezing eggs or embryos, which increases the chances of conceiving with proper diet factors and elevates the growth rate of the IVF market.

According to the latest data from the Centre for Disease Control and Prevention, more than 47% of embryo transfers are successful every year, particularly in the U.S., with the availability of advanced healthcare infrastructure. The rising awareness among the public to conceive through IVF procedures through various digital platforms, even in undeveloped countries, is likely to promote huge opportunities for the market. In addition, rising people’s interest in spending on healthcare to conceive without any risks of failure is ascribed to boost the growth rate of the market.

Market Restraints:

IVF procedure involves high-cost factors where common people can afford it easily. The process of invitro fertilization involves, in many ways, the most advanced equipment where those costs are high, which is specifically one of the most common factors degrading the growth rate of the market. The lack of a skilled workforce during the IVF process slightly limits the growth rate of the market. Many believe that this procedure is slightly painful and requires frequent hospital visits, which are time-consuming. These factors may also impede the growth rate of the market.

Segmental  Analysis:

By Reagents and Media

• Embryo Culture Media
• Cryopreservation Media
• Sperm Processing Media
• Ovum Processing Media

The embryo culture media segment is leading with the largest share of the IVF market. This type of media nurtures the embryo to grow and develop under certain circumstances and can be used to transfer healthy embryos that have a high chance of success rate in the IVF procedure. Sperm processing media augmented and dominated the fastest growth rate during the forecast period.

By Instruments

• Imaging Systems
• Sperm Separation Systems
• Ovum Aspiration Pumps
• Incubators
• Micromanipulator Systems
• Cryptosystems
• Other Instruments (Gas Analyzers, Laser Systems, and Accessories)

The imaging systems segment is gaining huge traction over the share of the market. These systems have a vital role in promoting the IVF procedure as a careful guide. These systems help detect subtle issues and help healthcare providers develop precise treatment techniques accordingly. Ovum aspiration pumps segment is likely to have the highest CAGR during the forecast period.

By Technology

• Intra-Cytoplasmic Sperm Injection (ICSI)
• Pre-Implantation Genetic Diagnosis (PGD)
• Frozen Embryo Transfer/Replacement (FET/FER)
• Other Technologies

The intracytoplasmic sperm injection segment is gearing with the highest share of the IVF market with the growing number of women suffering from various hormonal imbalances issues. PCOD has become one of the most common diseases among women in recent times, which is substantially leading to infertility. ICSI is grateful for increasing the chances of conceiving with minimal effort. PGD segment will eventually have the fastest growth opportunities in the coming years.

By End Users

• Fertility and Surgical Centers
• Hospitals and Research Laboratories
• Cryobanks

The fertility and surgical centers segment is thriving and holding the largest share of the market throughout the forecast period. With the growing number of infertile couples, there is a rising number of new fertility care centers across the globe with skilled practitioners. The hospitals and research laboratories segment shall have a significant growth rate throughout the forecast period. Growing concern over the adoption of new technologies to improve treatment options for infertility issues is attributed to escalating the growth rate of the market.

Regional Analysis:

Asia Pacific IVF market is ascribed to having a prominent growth rate with the rising adult population. Emerging countries like India and China are showcased to promote the huge opportunities for fertility treatment procedures with growing support from government organizations. Huge investments in the R&D activities in Chinese laboratories to develop innovative procedures to improve fertility treatment procedures at affordable prices with all the latest technologies shall promote the growth rate of the market in this region.

The North American IVF market is likely to have the highest CAGR by the end of 2032. Improved healthcare infrastructure and the launch of advanced technologies to improve the success rate of IVF procedures shall increase the growth rate of the market. Europe is esteemed to have a significant growth rate during the forecast period.

Recent Market Developments:

In 2023, ThermoFisher  Scientific Inc. launched two next-generation sequencing-based options that help in IVF and ICSI research activities. These two kits, the Ion ReproSeq PGT-A Kit* and the Ion AmpliSeq Polyploidy, help in research activities to launch more treatment options in the future.

Key Players:

Some of the notable participants operating in the global IVF market profiled in the report are CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.).

Browse full details of the report @ https://www.marketdataforecast.com/market-reports/in-vitro-fertilization-market

Related Report

Fertility Tourism Market

Home Insemination Products Market

ABOUT US

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

Contact Us

Market Data Forecast

www.marketdataforecast.com

Phone: +1-888-702-9626

Email: sales@marketdataforecast.com

Naijamatta is a social networking site,

download Naijamatta from Google play store or visit www.naijamatta.com to register. You can post, comment, do voice and video call, join and open group, go live etc. Join Naijamatta family, the Green app.